Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - INTEREST INCOME & EXPENSE
Interest Income & Expense FOLD - Amicus Therapeutics, Inc.
49.6 M
LAST VALUE
15.59%
2 YEAR CAGR
21.32%
5 YEAR CAGR
42.04%
10 YEAR CAGR